A novel seven‑gene panel predicts prognosis of head and neck squamous cell carcinoma treated with platinum‑based radio(chemo)therapy

Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3597-3598. doi: 10.1007/s00405-021-06760-2. Epub 2021 Mar 26.

Authors

Yuan-Fei Shi¹, Wan-Zhuo Xie²

Affiliations

¹ Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China.
² Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China. xiewanzhuo@zju.edu.cn.

PMID: 33770246
DOI: 10.1007/s00405-021-06760-2

No abstract available

Publication types

Letter

MeSH terms

Chemoradiotherapy
Head and Neck Neoplasms* / therapy
Humans
Platinum*
Prognosis
Squamous Cell Carcinoma of Head and Neck / genetics
Squamous Cell Carcinoma of Head and Neck / therapy

Substances

Platinum